Spots Global Cancer Trial Database for pancreatic cancer resectable
Every month we try and update this database with for pancreatic cancer resectable cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma | NCT05483257 | Pancreatic Canc... | Multigene panel... | 34 Years - 84 Years | Ruijin Hospital | |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | NCT05637567 | Pancreatic Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | German Cancer Research Center | |
| EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial) | NCT06375928 | Malignant Bilia... Pancreatic Canc... Biliary Tract N... | Endoscopic bili... Self-expandable... Lumen-apposing ... | 18 Years - | Hospital Universitari de Bellvitge | |
| Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms | NCT05287165 | Advanced Solid ... Digestive Syste... Pancreatic Canc... Colorectal (Col... | IM96 CAR-T cell... | 18 Years - 75 Years | Beijing Immunochina Medical Science & Technology Co., Ltd. | |
| Pancreatic Cancer Detection Consortium | NCT06388967 | Pancreatic Canc... Pancreatic Carc... Pancreatic Aden... Pancreatic Duct... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | PANcreatic canc... | 18 Years - | City of Hope Medical Center | |
| ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma | NCT05479708 | Pancreatic Canc... | ctDNA-based MRD... | 18 Years - 75 Years | Ruijin Hospital | |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | NCT05637567 | Pancreatic Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | German Cancer Research Center | |
| Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients. | NCT04224402 | Pancreatic Canc... | mFOLFORINOX | 18 Years - 79 Years | Sun Yat-sen University | |
| EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial) | NCT06375928 | Malignant Bilia... Pancreatic Canc... Biliary Tract N... | Endoscopic bili... Self-expandable... Lumen-apposing ... | 18 Years - | Hospital Universitari de Bellvitge | |
| Pancreatic Cancer Detection Consortium | NCT06388967 | Pancreatic Canc... Pancreatic Carc... Pancreatic Aden... Pancreatic Duct... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | PANcreatic canc... | 18 Years - | City of Hope Medical Center | |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | NCT05637567 | Pancreatic Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | German Cancer Research Center | |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | NCT03977233 | Pancreatic Duct... Cancer of Pancr... Pancreatic Canc... Pancreas Adenoc... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Oxaliplatin Leucovorin Irinotecan Hydr... 5-FU | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors | NCT05181605 | Pancreatic Aden... Pancreatic Canc... | Folfirinox and ... | 18 Years - 70 Years | Instituto de investigación e innovación biomédica de Cádiz | |
| Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid | NCT04736043 | Pancreatic Canc... | Organoid | 18 Years - | Samsung Medical Center | |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | NCT03977233 | Pancreatic Duct... Cancer of Pancr... Pancreatic Canc... Pancreas Adenoc... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Oxaliplatin Leucovorin Irinotecan Hydr... 5-FU | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
